Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Stock Information for Outset Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Outset Medical Inc.

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the Firm
Outset Medical Reports Third-Quarter Results
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo® Hemodialysis System
Outset Medical to Present at the 2025 Stifel Healthcare Conference
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.